Yakup Ergun, Medical Oncologist at Antalya City Hospital, shared a post on X, about recent paper published in Lung Cancer:
Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.
Authors: Michael Snidera, Joseph K. Salama, Matthew Boyer.
”Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC.
Retrospective, 1:1:1 matching.
Survival rates were better in the lobectomy and sub-lobar resection group compared to SBRT, with lower rates of regional recurrence observed.”
Source: Yakup Ergun/X
